Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Integrin targeting agents and in-vivo and in-vitro imaging methods using the same

Integrin targeting agents and in-vivo and in-vitro imaging methods using the same

US Patent 8685370 · Granted Apr 1, 2014

Estimated economic value: $62,211,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NIR to SWIR fluorescent compounds for imaging and detection2023
Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels2019
Methods and compositions for identifying subjects at risk of developing stent th2018
Fluorescent imaging agents2018
Fused tricyclic heterocyclic compounds as HIV integrase inhibitors2018
Biocompatible fluorescent metal oxide nanoparticles2018
Substituted quinolizine derivatives useful as HIV integrase inhibitors2018
4-pyridinonetriazine derivatives as HIV integrase inhibitors2017
Spirocyclic hetercycle compounds useful as HIV integrase inhibitors2017
Integrin targeting agents and in-vivo and in-vitro imaging methods using the sam2017
Integrin targeting agents and in-vivo and in-vitro imaging methods using the sam2017
Integrin targeting agents and in-vivo and in-vitro imaging methods using the sam2017